Bullfrog Ai Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bullfrog Ai Holdings Inc's ROI in the second quarter of 2026?
Bullfrog Ai Holdings Inc recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -150.34%.

Within the Healthcare sector 673 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4035 to 4260.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	12.18 %	-35.96 %	-54.64 %	-33.66 %	-23.34 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	7	5	2	2	2
Return On Investment (TTM)	-150.34 %	-217.79 %	-273.18 %	-218.2 %	-195.32 %
BFRG's Overall Ranking	# 4260	# 4035	# 3480	# 3739	# 3712
Seq. Investment Change TTM	43.02 %	17.24 %	-22.91 %	-13.22 %	-18.35 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-6	-6	-6	-7	-7

BFRG Company Profile >> Back to BFRG Roi Comparisons >> See Annual BFRG Return On Investment

Return On Investment BFRG's Ranking
Within:	No.
Industry	# 307
Sector	# 674
Overall	# 4260

Return On Investment Statistics
High	Average	Low
-130.79 %	-171.8 %	-273.18 %
(Jun 30 2024)		(Dec 31 2025)

News about Bullfrog Ai Holdings Inc Return on Investment ROI

Navigating Market Sentiments Bullfrog AIs Promising Advances in Bipolar Disorder Treatment Amidst Broader Market Fluctuations

August 15, 2024

The pharmaceutical and biotechnology industries are continuously influenced by advancements in drug discovery, the financial health of companies, and broader market trends. On July 25, 2024, significant news emerged that affected the stock market, particularly concerning Bullfrog AI Holdings, Inc. (NASDAQ: BFRG), a leader in AI-driven drug discovery. The company announced breakthroughs in its collaboration with the Lieber Institute for Brain Development that could reshape the treatment landscape for bipolar disorder. This article explores the implications of these developments for the pharmaceutical industry while contextualizing the market dynamics surrounding Bullfrog AI and other notable news impacting shares on the same day. Bullfrog AI s Breakthroughs in Bipolar Disorder TreatmentBullfrog AI Holdings is at the forefront of utilizing artificial intelligence in drug discovery, aiming to expedite the process of identifying effective therapeutic candidates. On July 25, the company reported significant advancements in its collaboration with the Lieber Institute for Brain Development. Their work focuses on understanding the genetic and molecular mechanisms associated with brain disorders like bipolar disorder. This partnership underscores the innovative potential of AI in pharmacology, presenting a paradigm shift in how psychiatric disorders can be approached.

Financial Statements
Bullfrog Ai Holdings Inc's II. Quarter Investments	$ 7 Millions	BFRG's Balance sheet
Bullfrog Ai Holdings Inc's II. Quarter Income	$ -1 Millions	Quarterly BFRG's Income Statement
BFRG's Income by Division		See BFRG's Income by Division

BFRG Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022
Total Investments in Millions	2	5	3	-3	0
Y / Y Investment Growth	-56.96 %	91.48 %	-	-	-
Net Income in Millions	-6	-7	-5	-3	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-304.17 %	-140.89 %	-206.61 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BFRG's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BFRG's Competitors
Subscribers only: Roi for Bullfrog Ai Holdings Inc's Suppliers
Subscribers only: Return On Investment for BFRG's Customers

Other Ratios
BFRG's Roa	BFRG's Inventory Turnover Ratio	BFRG's Growth Rates	BFRG's Dividend Statistics
	BFRG's Profitability Ratios	BFRG's Asset Turnover Ratio	BFRG's Dividend Growth
BFRG's Roe	BFRG's Valuation Ratios	BFRG's Financial Strength Ratios	BFRG's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:42:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.